Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Lymphadenopathies before and during the Pandemic COVID-19: Increasing Incidence of Metastases from Solid Tumors.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
- بيانات النشر:
Original Publication: Basel, Switzerland : MDPI AG, [2012]-
- نبذة مختصرة :
Since December 2019, the world has experienced a pandemic caused by SARS-CoV-2, a virus which spread throughout the world. Anti-COVID19 measures were applied to limit the spread of the infection, affecting normal clinical practice. In 2020, studies on the possible impact of the pandemic considering the screening programs for early diagnosis of cancer were conducted, resulting in a prediction of delayed diagnosis of cancer. We performed a retrospective monocentric study on patients who present with the onset of lymphadenomegalies evaluated at our Hematological Department from February 2019 to October 2021 and undergoing excisional lymph-node biopsy. Three periods were considered: pre-pandemic, first pandemic period and second pandemic period (Group A, B and C). We included 258 patients who underwent a surgical biopsy and received a histological diagnosis. Hematological evaluation of outpatients sent by the general practitioner and surgical biopsies did not decrease among the three groups, despite limitations placed during this pandemic as well as new diagnoses of hematological malignancies. However, the diagnosis of metastatic cancer significantly increased from 2019 (7.8%) to 2021 (22.1%) ( p = 0.042). Our data supports the hypothesis that the pandemic affected the national screening programs of early cancer detection.
- References:
Front Aging Neurosci. 2021 Jan 12;12:614650. (PMID: 33510633)
Front Oncol. 2020 Aug 14;10:1439. (PMID: 32923397)
Br J Cancer. 2021 Feb;124(4):710-712. (PMID: 33250510)
Cancer Treat Res Commun. 2022;31:100553. (PMID: 35421819)
Physiol Genomics. 2020 Nov 1;52(11):549-557. (PMID: 32991251)
Genes (Basel). 2022 Sep 26;13(10):. (PMID: 36292613)
Cancer. 2022 Mar 1;128(5):1048-1056. (PMID: 34866184)
Oncol Lett. 2021 Dec;22(6):856. (PMID: 34777590)
Einstein (Sao Paulo). 2021 Dec 20;19:eAO6721. (PMID: 34932776)
Mitochondrion. 2022 Jan;62:151-158. (PMID: 34890822)
Breast. 2020 Dec;54:52-55. (PMID: 32919172)
Appl Health Econ Health Policy. 2020 Aug;18(4):509-517. (PMID: 32495067)
In Vivo. 2020 Sep-Oct;34(5):3047-3053. (PMID: 32871851)
Int J Colorectal Dis. 2020 Oct;35(10):1951-1954. (PMID: 32500432)
Lancet Oncol. 2020 Aug;21(8):1035-1044. (PMID: 32702311)
BJU Int. 2022 Aug;130(2):262-270. (PMID: 35080142)
Int J Environ Res Public Health. 2021 Aug 28;18(17):. (PMID: 34501687)
J Gastrointest Cancer. 2021 Nov 29;:. (PMID: 34843058)
PLoS One. 2022 Jun 14;17(6):e0269827. (PMID: 35700180)
Lancet Oncol. 2020 Aug;21(8):1023-1034. (PMID: 32702310)
J Surg Oncol. 2021 Sep;124(3):261-267. (PMID: 34137039)
Viruses. 2020 Mar 27;12(4):. (PMID: 32230900)
- Contributed Indexing:
Keywords: hematological malignancies; lymph-node biopsy; lymphadenopathies; metastatic cancers; pandemic COVID-19; screening; solid tumors
- الموضوع:
Date Created: 20221211 Latest Revision: 20221221
- الموضوع:
20240829
- الرقم المعرف:
PMC9739990
- الرقم المعرف:
10.3390/jcm11236979
- الرقم المعرف:
36498559
No Comments.